Rapporten
Verificerede nyheder om finansiering, hovedkvarterer og ledelse fra verdens mest innovative virksomheder
26 rapporter og tæller
Dualitas Therapeutics Appoints Karim Dabbagh Chief Executive Officer
Dualitas Therapeutics appointed Karim Dabbagh, formerly President and CEO of Silver Creek Pharmaceuticals, as Chief Executive Officer, with former interim CEO Rich Murray remaining on the Board of Directors.
Diagonal Therapeutics Raises $125M Series B | Antibody Therapeutics
Biotech startup Diagonal Therapeutics secures $125 million Series B for rare genetic disease treatments.
Bambusa Therapeutics raises $90M Series A at $400M valuation
Bambusa Therapeutics raises $90M in Series A at $400M valuation. Bispecific antibodies for immunology...
Bambusa Therapeutics Raises $90M in Series A
Bambusa Therapeutics, a Biotech company based in San Francisco, CA, has raised $90M in Series A at a $400M valuation led by Arch Venture Partners, Foresite Capital.
Star Therapeutics raises $125M Series B at $600M valuation
Star Therapeutics raises $125M in Series B at $600M valuation. Antibody therapies for cancer...
AbCellera raises $555M Series B at $5.7B valuation
AbCellera raises $555M in Series B at $5.7B valuation. Antibody discovery platform...
Abcuro raises $200M Series C at $1.5B valuation
Abcuro raises $200M in Series C at $1.5B valuation. Antibody therapeutics for autoimmune diseases...
Star Therapeutics raises $125M Series D
Star Therapeutics raises $125M in Series D. Developing antibody therapies for autoimmune and inflammatory diseases...
ProfoundBio Raises $112M Series B
Clinical-stage oncology company developing antibody-drug conjugates (ADCs) for targeted cancer therapy
Viser 9 rapporter • Side 1 • Kategori: all
Hold dig foran markedet
Få ugentlig indsigt leveret til din indbakke. Ingen spam, kun intelligens.